Long-read sequencing-based diagnosis for complex genomic and DNA methylation changes
- Institution
- D4Z4 MEDICINE, INC., MD
- Principal investigator
- Yi-Wen Chen
- Funding
- $313K
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Structural changes in the genome and alterations of DNA methylation contribute to many diseases. Properly assessing these types of changes can be challenging using current technologies. One of the focuses of D4Z4 Medicine, Inc., is to provide long-read sequencing-based assays that can be used to determine structural variations and DNA methylation in one assay. In this proposal, we focus on a molecular diagnostic assay for facioscapulohumeral muscular dystrophy (FSHD). In addition to assay optimization, we will develop a user friendly and scalable data analysis tool, which will allow fast and accurate diagnostic report generation. In aim 1, we will standardize and validate the long-read sequencing assay. We will increase the capacity of the assay by adding additional target regions. We will also validate the assay using clinical samples. In aim 2, we will optimize a bioinformatics pipeline for analyzing long-read sequencing data containing D4Z4 repeat sequences and create a user-friendly interface. This approach developed here will provide a novel genetic diagnostic tool for FSHD which does not have an effective diagnostic tool. In addition, the assay and analysis tool will be expanded to cover additional genes and diseases.
LOADING MOONBASE SCORE
Questions for D4z4 Medicine, Inc.
D4z4 Medicine, Inc. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same topic, scored first.
- NSF · Tougaloo CollegeNot yet scored
Research Initiation Award: Uncovering and Extracting Biological Information from Nanopore Long-read Sequencing Data with Machine Learning and Mathematical Approaches
Xiuquan Wang · $300K · 2023–2026
- NIH · Children'S Hosp of PhiladelphiaNot yet scored
Utilizing long-read sequencing to resolve inconclusive diagnoses and uncertainty in genetic testing
Ramakrishnan Rajagopalan · $445K · 2024–2028
- NIH · Baylor College of MedicineNot yet scored
Identification of somatic/ mosaic SV and transposon activity and their crosstalk to DNA epigenetic Modifications
Fritz J Sedlazeck · $504K · 2023–2028